DR6 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ACADIA Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 22.25 EUR 8.48% Market Closed

Market Cap: €3.7B

A	ACADIA Pharmaceuticals Inc F:DR6	US
	Fresnillo PLC LSE:FRES	MX
C	China Oilfield Services Ltd OTC:CHOLF	CN
	Perrigo Company PLC F:PIG	IE
	Stadio Holdings Ltd F:0JX	ZA
I	IDEXX Laboratories Inc F:IX1	US

Profitability Summary

ACADIA Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

92%

Strong 3Y Average Gross Margin

97%

Declining Gross Margin

98% > 92%

Low Operating Margin

10%

Strong 3Y Average Operating Margin

33%

Operating Margin is Increasing

-23% > 10%

Exceptional Net Margin

36%

Strong 3Y Average Net Margin

47%

Net Margin is Increasing

-20% > 36%

Healthy Free Cash Flow Margin

Strong 3Y Average Free Cash Flow Margin

19%

Free Cash Flow Margin is Increasing

-30% > 1%

Exceptional ROE

40%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

88%

ROIC is Increasing

-65% > 834%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.